DO

Doximity, Inc.

DOCSHealthcareNASDAQ

Health Information Services

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$644.9M
+13.1% YoY
Net Income
$196.1M
-12.2% YoY
EBITDA
$229.3M
-4.8% YoY
Free Cash Flow
$255.3M

Scan Results

Daily timeframe
DateIndicatorDetails
Jul 7 RSI OverboughtRSI 70.1, above 70, stock may be overbought
Jun 23 RSI OversoldRSI 22.7, below 30, stock may be oversold
About Doximity, Inc.

Part of the healthcare sector, Doximity, Inc. (DOCS) is listed under Health Information Services. Valued at $3.87B, DOCS is a mid-cap name in its sector. Its Doximity platform includes a personalized newsfeed that presents clinical and professional content to members, which offers medical articles, clinical trials or research results in an easy-to-consume video format, professional updates and accomplishments of their peers and colleagues, clinical discussions, Op-Med articles for publication, and sponsored content from pharmaceutical manufacturers and health systems.

Key stats
Market Cap$3.87B
P/E (TTM)22.65
Fwd P/E13.50
EPS$0.95
Beta1.29
52W Change-64.2%
ROE19.3%
Analysis

Doximity, Inc. holds $748.6M in cash against $10.2M in total debt, giving it a net cash position. This means the company could theoretically pay off all its debt and still have cash remaining. Free cash flow comes in at $255.3M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of 19.3% points to strong capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Return on assets of 11.6% further supports the picture of efficient asset utilization. Revenue has grown from $419.1M (2023) to $644.9M (2026), reflecting a 54% increase over the period.

The strong cash position relative to debt provides a financial cushion that reduces balance sheet risk. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Doximity, Inc.'s trajectory.

Links
More Healthcare stocks
Browse all stocks →
Not financial advice. Scanance is an educational tool. Past performance does not guarantee future results.PrivacyTerms